There were 1,780 press releases posted in the last 24 hours and 430,006 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Replimune Announces Initiation of the Phase 2 Portion of its Ongoing Phase 1/2 Clinical Trial of RP1 as Monotherapy and in Combination with Nivolumab

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image